Home/Filings/4/0001654954-24-007462
4//SEC Filing

Cornell Alison A 4

Accession 0001654954-24-007462

CIK 0001101026other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 6:27 PM ET

Size

17.5 KB

Accession

0001654954-24-007462

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Award

    Common Stock

    2024-06-05+60,724144,578 total
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-053,1790 total
    Exercise: $26.88Exp: 2031-10-11Common Stock (3,179 underlying)
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-057070 total
    Exercise: $17.16Exp: 2032-12-15Common Stock (707 underlying)
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-0523,2400 total
    Exercise: $15.66Exp: 2032-12-18Common Stock (23,240 underlying)
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-053,6260 total
    Exercise: $16.74Exp: 2033-06-11Common Stock (3,626 underlying)
  • Award

    Common Stock

    2024-06-05$7.96/sh+95,134$757,267239,712 total
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-052,6320 total
    Exercise: $21.66Exp: 2032-07-27Common Stock (2,632 underlying)
Footnotes (4)
  • [F1]The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
  • [F2]The canceled options were fully vested.
  • [F3]The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock.
  • [F4]The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vested as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.

Issuer

Zivo Bioscience, Inc.

CIK 0001101026

Entity typeother

Related Parties

1
  • filerCIK 0001549395

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:27 PM ET
Size
17.5 KB